PODD currently has a PEG ratio reading of 0.42 as of Sep 11, 2026. This value reflects a P/E ratio of 24.67 measured against EPS growth of 58.8%.
A eight years lookback shows an average PEG ratio of 3.98 for Insulet. Compared to historical data, PODD's 0.42 PEG ratio represents a decrease of 89%. PODD reached its maximum PEG ratio of 24.85 during the Mar 2021 quarter over the past eight years. The Mar 2024 quarter had the bottom reading at 0, indicating the most optimal growth-adjusted valuation.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | N/A | 80.98 | -41.2% |
| 2024 | 0.43 | 43.73 | 101.7% |
| 2023 | 0.02 | 73.3 | 4,128.6% |
| 2022 | N/A | 4,205.57 | -72% |
| 2021 | 8.36 | 1,064.28 | 127.3% |
| 2020 | N/A | 2,323.91 | -42.1% |
| 2019 | 4.16 | 901.05 | 216.7% |
| 2018 | 11.7 | 1,322 | 113% |
| 2017 | N/A | N/A | 9.8% |
| 2016 | N/A | N/A | 60.5% |
| 2015 | N/A | N/A | -40.2% |
| 2014 | N/A | N/A | -10.8% |
| 2013 | N/A | N/A | 23.1% |
| 2012 | N/A | N/A | -10.2% |
| 2011 | N/A | N/A | 36.4% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Jun 2026 | 0.48 | 28.46 | 58.8% |
| Mar 2026 | N/A | 48.8 | -25.1% |
| Dec 2025 | N/A | 80.98 | -41.2% |
| Sep 2025 | N/A | 88.21 | -41.9% |
| Jun 2025 | N/A | 93.23 | -40.4% |
| Mar 2025 | 0.64 | 45.75 | 71.3% |
| Dec 2024 | 0.43 | 43.73 | 101.7% |
| Sep 2024 | 0.15 | 38.66 | 250% |
| Jun 2024 | 0.07 | 35.72 | 527.8% |
| Mar 2024 | 0 | 51.16 | 33,400% |
| Dec 2023 | 0.02 | 73.3 | 4,128.6% |
| Sep 2023 | 0.16 | 92.73 | 588% |
| Jun 2023 | 4.19 | 320.38 | 76.5% |
| Mar 2023 | N/A | 31,896 | -98.4% |
| Dec 2022 | N/A | 4,205.57 | -72% |
When comparing to historical values, PODD's PEG ratio is higher than its 3-year average, yet it is below the 5 and 10-year averages.
With a PEG of 0.42, PODD stands below the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 0.53, Insulet's PEG is 21% lower.
Compared to its peers, PODD's PEG ratio is under MDT's and ICUI's but above LLY's and DXCM's. With a PEG ratio of 0.42, Insulet stands lower than the 0.83 peer average.
PODD's Sep 11, 2026 PEG ratio comes in at 0.42.
Over the last 3 years, PODD's PEG ratio has settled near 0.24.
Over the last 5 years, PODD's PEG ratio has settled near 1.81.
In the last eight years, PODD's peak PEG ratio of 24.85 was recorded in the Mar 2021 quarter.
Currently, PODD's PEG ratio is 89% lower than its 8-year historical average.
At 0.42, PODD's PEG ratio suggests the stock may be attractively priced given its growth rate.
Computing the PEG ratio involves dividing the PE ratio by the company's EPS growth (YoY TTM). As of Sep 11, 2026, Insulet has a P/E ratio of 24.67. Earnings grew at 58.8% over the TTM period ending Jun 2026. Applying the formula, this produces a price to earnings growth ratio of 0.42. PEG RATIO(0.42) = PE RATIO(24.67) / EPS GROWTH(58.8%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.